activesellsec_filings

GSAT 10-Q report for 2025-09-30

Globalstar, Inc. (GSAT) filed its Form 10‑Q for the quarter ended September 30, 2025. The filing includes condensed consolidated financial statements, selected income statement and balance sheet line items, share counts (post 1:15 reverse split), and customary forward‑looking statement disclosures. The report confirms quarterly revenue, operating expenses, net income/(loss) and principal balance sheet aggregates as filed with the SEC.

Confidence
60 / 100
Assets
1
Authors
1
Outcome
open

Linked assets

GSAT — Globalstar, Inc.: Form 10‑Q for period ended 2025‑09‑30. Filing includes condensed consolidated statements of operations and balance sheets, notes on reverse stock split, and summary table of results for three‑ and nine‑month periods.

GSATsellopen

Globalstar, Inc. (GSAT) — Form 10‑Q for quarter ended September 30, 2025. Filing contains condensed consolidated financial statements and standard SEC cover page/forward‑looking disclosures. Reported three‑month revenue $73,845k, operating income $10,156k, net income $1,090k; total assets $2,162,350k and total liabilities $1,797,525k as of September 30, 2025. Shares outstanding post 1:15 reverse split: 126,821,483 common; 149,425 preferred.

Confidence: 60 / 100Start: $48.25Latest: $82.19Return: -70.34%

The submitted 10‑Q includes the SEC cover page and unaudited condensed consolidated financial statements for Globalstar, Inc. (GSAT) for the quarter ended September 30, 2025. Key reported items: three months ended 9/30/25 — total revenue $73.845M; income from operations $10.156M; net income $1.090M; basic weighted‑average shares 126,688. Balance sheet highlights at 9/30/25: cash and equivalents $346.293M; total assets $2,162.350M; total liabilities $1,797.525M; stockholders’ equity $364.825M. The filing discloses the 1:15 reverse stock split effective February 10, 2025 and restated historical share figures. The document primarily provides reported figures and standard forward‑looking disclosures; it is actionable for confirming the filing and for capital‑structure and near‑term operating result checks, but lacks the full MD&A or detailed footnote analysis necessary for high‑confidence directional trading calls on its own.

Source proof

Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review

Primary source: Globalstar, Inc. Form 10‑Q filed with the SEC for the quarter ended September 30, 2025 (Commission file number 001-33117). Document includes financial statements (unaudited), condensed consolidated balance sheets and statements of operations, and the standard cautionary forward‑looking statement language.

SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

This excerpt is only the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source
ABCL 10-Q report for 2026-03-31
AbCellera Biologics Inc. · May 11, 2026, 4:18 PM EDT

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.

View source

Supporting authors

Document authored and filed by Globalstar, Inc. (Registrant). Page summaries and analysis provided by the research team; no independent audit was performed by the research team.

Unlock full thesis monitoring

Use this filing to verify reported quarterly results, balance sheet aggregates, and outstanding share counts. For trade decisions, supplement with MD&A, footnotes, and subsequent disclosures; consider capital‑structure and liquidity implications disclosed in the 10‑Q.